138 related articles for article (PubMed ID: 8992998)
21. [Towards a vaccine for HIV infection: role of the gp41 envelope protein].
Debre P; Costagliola D; Legrand R; Vieillard V
Bull Acad Natl Med; 2009 Jan; 193(1):127-36; discussion 137-8. PubMed ID: 19718985
[TBL] [Abstract][Full Text] [Related]
22. Resistance to viral infection by intraepithelial lymphocytes in HIV-1 P18-I10-specific T-cell receptor transgenic mice.
Kuribayashi H; Wakabayashi A; Shimizu M; Kaneko H; Norose Y; Nakagawa Y; Wang J; Kumagai Y; Margulies DH; Takahashi H
Biochem Biophys Res Commun; 2004 Apr; 316(2):356-63. PubMed ID: 15020225
[TBL] [Abstract][Full Text] [Related]
23. The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets.
McKinney DM; Lewinsohn DA; Riddell SR; Greenberg PD; Mosier DE
J Immunol; 1999 Jul; 163(2):861-7. PubMed ID: 10395680
[TBL] [Abstract][Full Text] [Related]
24. HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokines.
Wilson CC; Olson WC; Tuting T; Rinaldo CR; Lotze MT; Storkus WJ
J Immunol; 1999 Mar; 162(5):3070-8. PubMed ID: 10072560
[TBL] [Abstract][Full Text] [Related]
25. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
26. Vaccine-induced CD8+ T lymphocytes of rhesus monkeys recognize variant forms of an HIV epitope but do not mediate optimal functional activity.
Hulot SL; Cale EM; Korber BT; Letvin NL
J Immunol; 2011 May; 186(10):5663-74. PubMed ID: 21490161
[TBL] [Abstract][Full Text] [Related]
27. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
28. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.
van Baalen CA; Guillon C; van Baalen M; Verschuren EJ; Boers PH; Osterhaus AD; Gruters RA
Eur J Immunol; 2002 Sep; 32(9):2644-52. PubMed ID: 12207349
[TBL] [Abstract][Full Text] [Related]
29. Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection.
Brander C; Goulder PJ; Luzuriaga K; Yang OO; Hartman KE; Jones NG; Walker BD; Kalams SA
J Immunol; 1999 Apr; 162(8):4796-800. PubMed ID: 10202022
[TBL] [Abstract][Full Text] [Related]
30. V3 CTL epitope density in a single recombinant molecule antigen differentially affects the number and activity of primary and memory CD8+ T cells.
Lu L; Zhu Y; Diao J; Wang Z; Chen YH
Vaccine; 2008 Feb; 26(6):845-52. PubMed ID: 18191003
[TBL] [Abstract][Full Text] [Related]
31. Role of preimmunization virus sequences in cellular immunity in HIV-infected patients during HIV type 1 MN recombinant gp160 immunization.
Kundu SK; Dupuis M; Sette A; Celis E; Dorner F; Eibl M; Merigan TC
AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1669-78. PubMed ID: 9870321
[TBL] [Abstract][Full Text] [Related]
32. Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site. Implications for the mechanism of processing of viral envelope proteins.
Ferris RL; Buck C; Hammond SA; Woods AS; Cotter RJ; Takiguchi M; Igarashi Y; Ichikawa Y; Siliciano RF
J Immunol; 1996 Jan; 156(2):834-40. PubMed ID: 8543840
[TBL] [Abstract][Full Text] [Related]
33. Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor.
Callahan KM; Fort MM; Obah EA; Reinherz EL; Siliciano RF
J Immunol; 1990 May; 144(9):3341-6. PubMed ID: 1970352
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of HIV persistence: implications for vaccines and therapy.
Bremermann HJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):459-83. PubMed ID: 7627623
[TBL] [Abstract][Full Text] [Related]
35. N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes.
Botarelli P; Houlden BA; Haigwood NL; Servis C; Montagna D; Abrignani S
J Immunol; 1991 Nov; 147(9):3128-32. PubMed ID: 1717587
[TBL] [Abstract][Full Text] [Related]
36. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication.
Bollinger RC; Quinn TC; Liu AY; Stanhope PE; Hammond SA; Viveen R; Clements ML; Siliciano RF
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1067-77. PubMed ID: 7906131
[TBL] [Abstract][Full Text] [Related]
37. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.
Ferrari G; Humphrey W; McElrath MJ; Excler JL; Duliege AM; Clements ML; Corey LC; Bolognesi DP; Weinhold KJ
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1396-401. PubMed ID: 9037064
[TBL] [Abstract][Full Text] [Related]
38. Human CD4+ cytolytic T lymphocyte responses to a human immunodeficiency virus type 1 gp160 subunit vaccine.
Stanhope PE; Clements ML; Siliciano RF
J Infect Dis; 1993 Jul; 168(1):92-100. PubMed ID: 8099941
[TBL] [Abstract][Full Text] [Related]
39. Autologous strain-specific cytolytic T lymphocyte responses directed against human immunodeficiency virus type 1 Env.
Ray SC; Lubaki N; Dhruva BR; Siliciano RF; Bollinger RC
AIDS Res Hum Retroviruses; 1998 Jan; 14(1):3-13. PubMed ID: 9453246
[TBL] [Abstract][Full Text] [Related]
40. T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4(+) cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide.
Bouhdoud L; Villain P; Merzouki A; Arella M; Couture C
J Virol; 2000 Mar; 74(5):2121-30. PubMed ID: 10666241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
